Systemic Organophosphate Poisoning following the Percutaneous Injection of Insecticide: Case Report
Organophosphates are the most common group of chemicals in the southern part of Turkey. Although organophosphate poisoning (OPP) may occur due to skin exposure or inhalation, severe poisoning is usually the result of ingestion to attempt suicide. Despite the fact that there have been a lot of experi...
Gespeichert in:
Veröffentlicht in: | Skin pharmacology and physiology 2002-05, Vol.15 (3), p.195 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 3 |
container_start_page | 195 |
container_title | Skin pharmacology and physiology |
container_volume | 15 |
creator | Hadimioglu, Necmiye Dosemeci, Levent Arici, Gulbin Ramazanoglu, Atilla |
description | Organophosphates are the most common group of chemicals in the southern part of Turkey. Although organophosphate poisoning (OPP) may occur due to skin exposure or inhalation, severe poisoning is usually the result of ingestion to attempt suicide. Despite the fact that there have been a lot of experimental studies using intravenous or percutaneous injection of organophosphates, reports of human poisoning due to percutaneous injection are rare. The systemic signs of OPP have not been described in these reported patients. We report 2 cases having systemic signs of OPP due to percutaneous injection. In our first case, we noticed a 17-day muscle weakness and a 12-day muscarinic syndrome, which required prolonged atropinization. In the second patient, atropine infusion had to be continued for 2 days. Both cases also had severe swelling of the affected limb and wound infection. In conclusion, in cases of percutaneous injection of organophosphates systemic toxicity may develop in addition to local findings such as necrosis and abscesses. Close observation for evidence of systemic involvement is required, and the patient should be carefully monitored for secondary abscess formation and any delayed impairment of neurologic function. Copyright © 2002 S. Karger AG, Basel |
format | Article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_225270910</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>738490651</sourcerecordid><originalsourceid>FETCH-proquest_journals_2252709103</originalsourceid><addsrcrecordid>eNqNjjsLwjAUhYMoWB__IbgX0pSmOIuik4LiWkJM25SaW3MTxH9vBHF2Ot95DGdEkkwIlhZFXox_zMspmSF2jHFRZiIh1_MLvb4bRY-ukRaGFnBopdf0BAbBGtvQGvoenh_ybcy1U8FLqyEgPdhOK2_AUqijwY9R5qYXZFLLHvXyq3Oy2m0vm306OHgEjb7qIDgbq4rz-IqtM5b_NXoDPQ5DGw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>225270910</pqid></control><display><type>article</type><title>Systemic Organophosphate Poisoning following the Percutaneous Injection of Insecticide: Case Report</title><source>Karger Journals</source><creator>Hadimioglu, Necmiye ; Dosemeci, Levent ; Arici, Gulbin ; Ramazanoglu, Atilla</creator><creatorcontrib>Hadimioglu, Necmiye ; Dosemeci, Levent ; Arici, Gulbin ; Ramazanoglu, Atilla</creatorcontrib><description>Organophosphates are the most common group of chemicals in the southern part of Turkey. Although organophosphate poisoning (OPP) may occur due to skin exposure or inhalation, severe poisoning is usually the result of ingestion to attempt suicide. Despite the fact that there have been a lot of experimental studies using intravenous or percutaneous injection of organophosphates, reports of human poisoning due to percutaneous injection are rare. The systemic signs of OPP have not been described in these reported patients. We report 2 cases having systemic signs of OPP due to percutaneous injection. In our first case, we noticed a 17-day muscle weakness and a 12-day muscarinic syndrome, which required prolonged atropinization. In the second patient, atropine infusion had to be continued for 2 days. Both cases also had severe swelling of the affected limb and wound infection. In conclusion, in cases of percutaneous injection of organophosphates systemic toxicity may develop in addition to local findings such as necrosis and abscesses. Close observation for evidence of systemic involvement is required, and the patient should be carefully monitored for secondary abscess formation and any delayed impairment of neurologic function. Copyright © 2002 S. Karger AG, Basel</description><identifier>ISSN: 1660-5527</identifier><identifier>EISSN: 1660-5535</identifier><language>eng</language><publisher>Basel: S. Karger AG</publisher><ispartof>Skin pharmacology and physiology, 2002-05, Vol.15 (3), p.195</ispartof><rights>Copyright (c) 2002 S. Karger AG, Basel</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Hadimioglu, Necmiye</creatorcontrib><creatorcontrib>Dosemeci, Levent</creatorcontrib><creatorcontrib>Arici, Gulbin</creatorcontrib><creatorcontrib>Ramazanoglu, Atilla</creatorcontrib><title>Systemic Organophosphate Poisoning following the Percutaneous Injection of Insecticide: Case Report</title><title>Skin pharmacology and physiology</title><description>Organophosphates are the most common group of chemicals in the southern part of Turkey. Although organophosphate poisoning (OPP) may occur due to skin exposure or inhalation, severe poisoning is usually the result of ingestion to attempt suicide. Despite the fact that there have been a lot of experimental studies using intravenous or percutaneous injection of organophosphates, reports of human poisoning due to percutaneous injection are rare. The systemic signs of OPP have not been described in these reported patients. We report 2 cases having systemic signs of OPP due to percutaneous injection. In our first case, we noticed a 17-day muscle weakness and a 12-day muscarinic syndrome, which required prolonged atropinization. In the second patient, atropine infusion had to be continued for 2 days. Both cases also had severe swelling of the affected limb and wound infection. In conclusion, in cases of percutaneous injection of organophosphates systemic toxicity may develop in addition to local findings such as necrosis and abscesses. Close observation for evidence of systemic involvement is required, and the patient should be carefully monitored for secondary abscess formation and any delayed impairment of neurologic function. Copyright © 2002 S. Karger AG, Basel</description><issn>1660-5527</issn><issn>1660-5535</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqNjjsLwjAUhYMoWB__IbgX0pSmOIuik4LiWkJM25SaW3MTxH9vBHF2Ot95DGdEkkwIlhZFXox_zMspmSF2jHFRZiIh1_MLvb4bRY-ukRaGFnBopdf0BAbBGtvQGvoenh_ybcy1U8FLqyEgPdhOK2_AUqijwY9R5qYXZFLLHvXyq3Oy2m0vm306OHgEjb7qIDgbq4rz-IqtM5b_NXoDPQ5DGw</recordid><startdate>20020501</startdate><enddate>20020501</enddate><creator>Hadimioglu, Necmiye</creator><creator>Dosemeci, Levent</creator><creator>Arici, Gulbin</creator><creator>Ramazanoglu, Atilla</creator><general>S. Karger AG</general><scope>3V.</scope><scope>7QO</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20020501</creationdate><title>Systemic Organophosphate Poisoning following the Percutaneous Injection of Insecticide</title><author>Hadimioglu, Necmiye ; Dosemeci, Levent ; Arici, Gulbin ; Ramazanoglu, Atilla</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_2252709103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hadimioglu, Necmiye</creatorcontrib><creatorcontrib>Dosemeci, Levent</creatorcontrib><creatorcontrib>Arici, Gulbin</creatorcontrib><creatorcontrib>Ramazanoglu, Atilla</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Skin pharmacology and physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hadimioglu, Necmiye</au><au>Dosemeci, Levent</au><au>Arici, Gulbin</au><au>Ramazanoglu, Atilla</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Systemic Organophosphate Poisoning following the Percutaneous Injection of Insecticide: Case Report</atitle><jtitle>Skin pharmacology and physiology</jtitle><date>2002-05-01</date><risdate>2002</risdate><volume>15</volume><issue>3</issue><spage>195</spage><pages>195-</pages><issn>1660-5527</issn><eissn>1660-5535</eissn><abstract>Organophosphates are the most common group of chemicals in the southern part of Turkey. Although organophosphate poisoning (OPP) may occur due to skin exposure or inhalation, severe poisoning is usually the result of ingestion to attempt suicide. Despite the fact that there have been a lot of experimental studies using intravenous or percutaneous injection of organophosphates, reports of human poisoning due to percutaneous injection are rare. The systemic signs of OPP have not been described in these reported patients. We report 2 cases having systemic signs of OPP due to percutaneous injection. In our first case, we noticed a 17-day muscle weakness and a 12-day muscarinic syndrome, which required prolonged atropinization. In the second patient, atropine infusion had to be continued for 2 days. Both cases also had severe swelling of the affected limb and wound infection. In conclusion, in cases of percutaneous injection of organophosphates systemic toxicity may develop in addition to local findings such as necrosis and abscesses. Close observation for evidence of systemic involvement is required, and the patient should be carefully monitored for secondary abscess formation and any delayed impairment of neurologic function. Copyright © 2002 S. Karger AG, Basel</abstract><cop>Basel</cop><pub>S. Karger AG</pub></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1660-5527 |
ispartof | Skin pharmacology and physiology, 2002-05, Vol.15 (3), p.195 |
issn | 1660-5527 1660-5535 |
language | eng |
recordid | cdi_proquest_journals_225270910 |
source | Karger Journals |
title | Systemic Organophosphate Poisoning following the Percutaneous Injection of Insecticide: Case Report |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T06%3A46%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Systemic%20Organophosphate%20Poisoning%20following%20the%20Percutaneous%20Injection%20of%20Insecticide:%20Case%20Report&rft.jtitle=Skin%20pharmacology%20and%20physiology&rft.au=Hadimioglu,%20Necmiye&rft.date=2002-05-01&rft.volume=15&rft.issue=3&rft.spage=195&rft.pages=195-&rft.issn=1660-5527&rft.eissn=1660-5535&rft_id=info:doi/&rft_dat=%3Cproquest%3E738490651%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=225270910&rft_id=info:pmid/&rfr_iscdi=true |